Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ECE1 | P42892 | 2/20 | 0.65 |
| ▸ | MME | P08473 | 2/20 | 0.65 |
| ▸ | ITGB3 | P05106 | 8/20 | 0.65 |
| ▸ | ITGA2B | P08514 | 8/20 | 0.65 |
| ▸ | CTSL | P07711 | 2/20 | 0.64 |
| ▸ | CTSB | P07858 | 2/20 | 0.64 |
| ▸ | CTSS | P25774 | 2/20 | 0.64 |
| ▸ | CTSK | P43235 | 2/20 | 0.64 |
| ▸ | TACR1 | P25103 | 2/20 | 0.62 |
| ▸ | TYR | P14679 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.60 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10507966 | 1.00 | ECE1 (0.65) | ECE1MMEITGB3ITGA2BCTSL | |
| SCHEMBL221300 | 1.00 | ECE1 (0.65) | ECE1MMEITGB3ITGA2BCTSL | |
| SCHEMBL6118298 | 1.00 | ECE1 (0.65) | ECE1MMEITGB3ITGA2BCTSL | |
| Water SCHEMBL8165165 | 0.99 | CTSL (0.66) | ECE1MMEITGB3ITGA2BCTSL | |
| Water SCHEMBL8394834 | 0.99 | CTSL (0.66) | ECE1MMEITGB3ITGA2BCTSL | |
| Hydrochloric Acid SCHEMBL11635370 | 0.99 | ECE1 (0.64) | ECE1MMEITGB3ITGA2BCTSL | |
| SCHEMBL20678118 | 0.95 | MME (0.67) | ECE1MMEITGB3ITGA2BCTSL | |
| SCHEMBL29400351 | 0.95 | MME (0.67) | ECE1MMEITGB3ITGA2BCTSL | |
| SCHEMBL10727026 | 0.95 | MME (0.67) | ECE1MMEITGB3ITGA2BCTSL | |
| SCHEMBL30600471 | 0.95 | MME (0.67) | ECE1MMEITGB3ITGA2BCTSL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 182 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115581629-A | Method for improving hair dyeing stability based on enzymatic oxidation | 天津大学 | 2023-01-10 | — | — | CN | claimed |
| CN-113244119-B | Method for dyeing hair in color based on enzymatic oxidation of tyrosine derivative | 天津大学 | 2022-10-04 | — | — | CN | claimed |
| CN-113244119-A | Method for dyeing hair in color based on enzymatic oxidation of tyrosine derivative | 天津大学 | 2021-08-13 | — | — | CN | claimed |
| EP-0049500-B1 | TYROSINE DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND THEIR USE IN THE SYNTHESIS OF PEPTIDES | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 1984-02-22 | — | — | EP | claimed |
| US-20260035394-A1 | 1`-CYANO NUCLEOSIDE ANALOGS AND USES THEREOF | GILEAD SCIENCES INC (US) | 2026-02-05 | — | — | US | disclosed |
| US-12404289-B2 | 1′-cyano nucleoside analogs and uses thereof | GILEAD SCIENCES, INC. (US) | 2025-09-02 | — | — | US | disclosed |
| EP-3980400-B1 | PEPTIDOMIMETICS FOR THE TREATMENT OF CORONAVIRUS AND PICORNAVIRUS INFECTIONS | UNIV EMORY (US) | 2025-08-06 | — | — | EP | disclosed |
| US-12268723-B2 | Peptidomimetics for the treatment of coronavirus and picorna virus infections | EMORY UNIVERSITY (US) | 2025-04-08 | — | — | US | disclosed |
| US-20240399776-A1 | COLOR DEVELOPER, THERMAL RECORDING MATERIAL, AND THERMAL RECORDING LAYER COATING MATERIAL | SANKO CO., LTD. (JP) | 2024-12-05 | — | — | US | disclosed |
| US-20240294489-A1 | LOW MOLECULAR WEIGHT PROTEIN DEGRADERS AND THEIR APPLICATIONS | CAPTOR THERAPEUTICS S.A. (PL) | 2024-09-05 | — | — | US | disclosed |
| US-20240287109-A1 | 1'-CYANO NUCLEOSIDE ANALOGS AND USES THEREOF | GILEAD SCIENCES, INC. | 2024-08-29 | — | — | US | disclosed |
| EP-3515896-B1 | CHIRAL CYCLEN COMPOUNDS AND THEIR USES | UNIV HONG KONG POLYTECHNIC (CN) | 2024-08-21 | — | — | EP | disclosed |
| WO-1992014706-A1 | CYCLOPENTANE-DERIVED GLUTARAMIDE ANTIHYPERTENSIVE AGENTS | PFIZER LIMITED (GB) | 1992-09-03 | — | — | WO | disclosed |
| US-5081246-A | Isoquinolino sulfonamino derivatives | Hidaka, Hiroyoshi (JP) | 1992-01-14 | — | — | US | disclosed |
| EP-0226304-B1 | COMPOSITION CONTAINING A PENEM OR CARBAPENEM ANTIBIOTIC | SANKYO COMPANY LIMITED (JP) | 1991-08-28 | — | — | EP | disclosed |
| CN-1044098-A | Compounds with vascular smooth muscle relaxing activity | HIDAKA HIROYOSHI (JP) | 1990-07-25 | — | — | CN | disclosed |
| US-4757066-A | Reduces renal toxicity | SANKYO COMPANY LIMITED (JP) | 1988-07-12 | — | — | US | disclosed |
| EP-0226304-A1 | Composition containing a penem or carbapenem antibiotic | SANKYO COMPANY LIMITED (JP) | 1987-06-24 | — | — | EP | disclosed |
| US-4591459-A | Intermediates for 6-(aminoacyloxymethyl) penicillanic acid 1,1-dioxides | PFIZER INC. (US) | 1986-05-27 | — | — | US | disclosed |
| US-4503040-A | 6-(Aminoacyloxymethyl)penicillanic acid 1,1-dioxides as beta-lactamase inhibitors | PFIZER INC. (US) | 1985-03-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240294489-A1 | LOW MOLECULAR WEIGHT PROTEIN DEGRADERS AND THEIR APPLICATIONS | MMP2, PSME2, PSME1 | ECE1 552/4885MME 47/4885ITGB3 3714/4885 |
| US-20240287109-A1 | 1'-CYANO NUCLEOSIDE ANALOGS AND USES THEREOF | TYMP, PNP, DUT | ECE1 255/4885MME 410/4885ITGB3 2839/4885 |
| US-12404289-B2 | 1′-cyano nucleoside analogs and uses thereof | TYMP, PNP, DUT | ECE1 293/4885MME 416/4885ITGB3 2614/4885 |
| US-12268723-B2 | Peptidomimetics for the treatment of coronavirus and picorna virus infections | ACE2, SARS1, HAVCR2 | ECE1 41/4885MME 9/4885ITGB3 2908/4885 |
| US-20260035394-A1 | 1`-CYANO NUCLEOSIDE ANALOGS AND USES THEREOF | PNP, SLC28A1, SLC29A1 | ECE1 425/4885MME 1827/4885ITGB3 2106/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.